CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-06 | Young Alethia Director | Sale | −4,666 | $39.79 | $186K | 9,067 |
| 2023-09-06 | Young Alethia Director | Option exercise · Stock Option (Right to Buy) | −7,000 | $27.85 | $195K | 0 |
| 2023-09-06 | Young Alethia Director | Option exercise · Stock Option (Right to Buy) | −4,666 | $27.85 | $130K | 7,334 |
| 2023-07-13 | Gravier Pierre CHIEF FINANCIAL OFFICER | Grant or award | +26,000 | 26,000 | ||
| 2023-07-13 | Gravier Pierre CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-06-07 | SCHMERTZLER MICHAEL Director | Sale 10b5-1 | −1,000 | $44.86 | $45K | 116,766 |
| 2023-06-06 | Bell William F. Jr. Director | Grant or award | +4,000 | 4,000 | ||
| 2023-06-06 | Bell William F. Jr. Director | Grant or award | +2,333 | 6,333 | ||
| 2023-06-06 | Bell William F. Jr. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-06-06 | Bell William F. Jr. Director | Grant or award · Stock Option (Right to Buy) | +5,834 | 5,834 | ||
| 2023-05-23 | Reeve Emma Director | Option exercise 10b5-1 | +157 | $33.63 | $5K | 7,357 |
| 2023-05-23 | Reeve Emma Director | Sale 10b5-1 | −157 | $59.52 | $9K | 7,200 |
| 2023-05-23 | Reeve Emma Director | Option exercise 10b5-1 | +1,093 | $33.02 | $36K | 8,293 |
| 2023-05-23 | Reeve Emma Director | Sale 10b5-1 | −1,093 | $59.53 | $65K | 7,200 |
| 2023-05-23 | Reeve Emma Director | Option exercise 10b5-1 | +1,402 | $33.63 | $47K | 8,602 |
| 2023-05-23 | Reeve Emma Director | Sale 10b5-1 | −1,402 | $59.54 | $83K | 7,200 |
| 2023-05-23 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −157 | $33.63 | $5K | 837 |
| 2023-05-23 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,093 | $33.02 | $36K | 6,912 |
| 2023-05-23 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,402 | $33.63 | $47K | 8,650 |
| 2023-05-22 | Reeve Emma Director | Option exercise 10b5-1 | +173 | $33.63 | $6K | 7,373 |
Page 37 of 41 · 804 trades